T HYROID HORMONES PLAY an important role in the growth, development, and turnover of bone by influencing the rate of bone resorption and formation. Children with juvenile hypothyroidism have growth arrest, delayed bone maturation, and epiphyseal dysgenesis. In contrast, thyrotoxic children have accelerated growth velocity and advanced bone maturation. Thyrotoxic adults are at risk of osteoporosis (1, 2) and increased mortality from fractures of the femur (3) . Increased bone formation and resorption in thyrotoxicosis suggest that both osteoblasts and osteoclasts are potential targets for T 3 action. Direct responsiveness of osteoclasts to T 3 has been disputed, and the majority of the actions of T 3 on bone are thought to be mediated via osteoblasts. In response to T 3 , osteoblasts are able to increase DNA synthesis and alkaline phosphatase (ALP) (4) and osteocalcin (5) production and are permissive for the action of osteoclasts on bone resorption (6, 7) .
TRs are central to conferring T 3 responsiveness to cells. They may bind to DNA as homodimers (8) or as heterodimers with 9-cis-RXR, which is also a common heterodimer partner for all-trans-RAR (9) . RXR and RAR are coexpressed with TRs in osteoblasts and modify the regulation of endogenous gene (ALP, osteocalcin, osteopontin) expression by T 3 in these cells (10) . There are two classes of TR in man, designated TR␣ and TR␤. Four principal TR isoforms have been described, namely ␣1, ␣2, ␤1, and ␤2, which result from alternative splicing. TR␣ isoforms differ in the carboxyl-terminal region of the ligand-binding domain, and ␤ isoforms differ in the amino-terminal. Thus, TR␣1, TR␤1, and TR␤2 bind T 3 , but TR␣2, lacking the terminal region of the ligand-binding domain, does not. TR␣1 and ␤1 mRNA and protein are expressed in a variety of tissues, although relative ratios of the isoforms may vary between tissues and during development. The ␤2 variant is also expressed more widely than initially thought, and protein expression has now been documented outside the brain, namely in heart, liver, and kidney.
The majority of studies on TR expression in osteoblasts have used rodent cell lines. Binding of radiolabeled [
125 I]T 3 has been documented in ROS 17/2.8, UMR 106, and MC3T 3 -E1 cell lines. Similarly, expression of isoform-specific TR mRNA by Northern blotting and of TR protein by Western analyses has been documented in both rodent cell lines (10) and primary cultures of rat osteoblasts (11) . No differences in TR isoform expression have been reported between bone derived from rat femoral and vertebral sites (12) , although subtle differences may be present in T 3 responsiveness with respect to ALP activity and gene expression of osteocalcin and IGF-I (13). Less is known about the expression and function of TRs in human osteoblasts. To date, TR protein has been identified by means of immunocytochemistry in the osteosarcoma-derived MG63 cell line (14) and in heterotopic bone (15) .
We have demonstrated elevated levels of IL-6 and IL-8 both in patients with thyrotoxicosis (16) and in cells of the osteoblast lineage stimulated with T 3 (17) . We documented differential responses to T 3 in osteoblasts derived from different sources. Human bone marrow stromal cells (hBMS), the source of osteoblast progenitor cells, are able to release the bone-resorbing and osteoclast-activating cytokines IL-6 and IL-8 in response to T 3 ; in contrast, primary human osteoblasts (hOb), cultured from explants of human trabecular bone, fail to produce IL-6 and IL-8 in response to T 3 . From these results a possible mechanism involving hBMS cells may be postulated for T 3 -induced bone resorption.
Studies of TR expression and function are pertinent to the understanding of bone physiology in normal and diseased states. The aim of our study therefore was to extend TR studies to human species to address the question of whether human osteoblasts possess TRs and whether the difference in T 3 -stimulated cytokine release between hOb and hBMS cells can be explained by differences in isoform-specific expression or function of TRs in these cells. We therefore studied the expression and function of the main T 3 -binding TR isoforms in primary cultures of human osteoblasts derived from trabecular bone and human bone marrow. For comparison, we also studied two human osteoblast-like cell lines, SaOs-2 and MG63.
Materials and Methods

Cell culture
The hOb-like cell lines MG63 and SaOs-2 were maintained in ␣MEM (Life Technologies, Inc., Paisley, UK) containing 10% FCS (Life Technologies, Inc.), penicillin, streptomycin, and fungizone (hereafter referred to as medium) at 37 C in a humidified atmosphere containing 5% CO 2 in air.
hBMS. The procedures for establishing primary osteoblast cultures from human bone marrow cells have been described previously (17, 18) . Bone marrow cells were obtained by iliac aspiration from normal healthy donors (age range, 18 -55 yr) who volunteered for the allogenic bone marrow transplantation program at the Hammersmith Hospital. Ethical approval was obtained from the Hammersmith Hospital research ethics committee. Marrow was diluted 1:1 with medium and centrifuged at 500 ϫ g for 10 min. Pelleted cells were resuspended in equal volumes of medium and Histopaque (specific gravity, 1077) and centrifuged for an additional 30 min at 1800 rpm. Mononuclear cells present in the interface were then harvested. Cells (5 ϫ 10 6 ) were plated in a 25-cm 2 tissue culture flask in medium containing 1% 200 mm l-glutamine (Life Technologies, Inc.) and 2 m methylprednisolone (Solumedrone, Upjohn Pharmaceuticals, Milton Keynes, UK). Cells were allowed to attach without disturbance for 7 d, after which medium was changed at 2-to 3-d intervals. At confluence, cells were trypsinized, counted, and plated into multiwell culture plates. First passage cells were used in all experiments.
hOb. The procedures for culturing hOb have been described previously (17) and are based on the method of Robey and Termine (19) . Femoral tissue was obtained from bone discarded during hip replacement surgery for osteoarthritis from 3 men, aged 70 -85 yr, and 4 women, aged 50 -75 yr. Given potential site-dependent differences in T 3 responsiveness (13), we used bone derived from the femoral site only. Trabecular bone was removed by scraping the surface with a bone curette and was minced into 2-to 4-mm pieces with dissecting scissors. The bone chips were then washed in PBS and incubated in serum-free medium containing 1 mg/ml collagenase (type IV, Sigma, St. Louis, MO). After 30 min, the supernatant fraction containing collagenase-released cells was discarded, and the bone chips were placed in tissue culture flasks in medium. Cells growing out from the bone chips were passaged once, and all assays were performed on cells subcultured at the end of the first passage. Exclusion criteria for all hOb and hBMS donors included the absence of medication that might affect the bone response to T 3 , specifically estrogens, glucocorticoids, and bisphosphonates.
Characterization of cell phenotype
Our culture conditions were based on the methodology of Haynesworth (20) and Rickard (21) , both of whom have extensively characterized their stromal cell population and found them to be predominantly of the osteogenic lineage following appropriate culture conditions. We also confirmed this (17) . Experiments were performed on first passage cells plated at a density of 10,000 cells/cm 2 (Table 1) .
For chondrocyte and adipocyte analyses, cells were fixed in formalin and stained for 30 min with Alcian blue (10% in 0.1 m HCl) for chondrocytes or overnight with Oil red O (0.5% in propylene glycol) for adipocytes (22) . No staining for mature chondrocytes or adipocytes was observed in any of the cell types.
Plasmids
All plasmids were obtained from Prof. V. K. K. Chatterjee (University of Cambridge, Cambridge, UK): TKLUC, containing the thymidine kinase (TK) gene promoter linked to a luciferase (LUC) reporter gene (23) , was used as a control. Thyroid hormone response element (TRE)-TKLUC, which incorporates two copies of a TRE (24) , was used to detect the presence of functioning endogenous T 3 receptors. RSVerbA␤, an expression vector containing the human thyroid hormone ␤1 receptor cDNA (25) , was used to determine the effect of excess T 3 receptors on TRE-TKLUC responsiveness. The expression vector Bos␤Gal contains the promoter of the human elongation factor 1␣ gene driving the expression of ␤-galactosidase (26) and was cotransfected as an internal control plasmid to normalize transfection efficiencies. 
Transient expression assays
All cells were plated at a density of 0.5 ϫ 10 6 cells/60-mm plate and incubated overnight. Thereafter, cells were transfected using the lipofection reagent dioleoyloxypropyl trimethyl ammonium methylsulfate (Roche Molecular Biochemicals, Lewes, UK). Dioleoyloxypropyl trimethyl ammonium methylsulfate (30 g) and purified plasmid DNA were each diluted in 20 mm HEPES and 150 mm NaCl, pH 7.4, before addition to each well. Cells were transfected with TKLUC (10 g), TRE-TKLUC (10 g), or a combination of RSVerbA␤ (1 g) and TRE-TKLUC (10 g) together with 3 g Bos␤Gal. Twenty-four hours later, cells were incubated in medium containing 10% charcoal-stripped FCS (GlobePharm, Surrey, UK) in the presence or absence of a physiological concentration (1 nm) of T 3 (Sigma). After overnight incubation, medium was removed, and cellular extracts were prepared and assayed for luciferase activity as described previously (27) . Luciferase data were normalized for ␤-galactosidase activity, which was assayed in the same cell extracts using a spectrophotometric microtiter plate assay with d-nitrophenyl-␤-O-galactopyranoside as substrate.
Nuclear protein extraction and Western blotting
Cells were plated into multiwell plates at a density of 1.5 ϫ 10 6 cells/60-mm plate in medium. After overnight incubation, cells were placed in fresh medium containing charcoal-stripped serum. Twentyfour hours later, they were treated with either 1 or 10 nm T 3 . Wells plated with osteoblastic cells were incubated with no additions and used as negative controls, and wells plated with GH 3 somatolactotroph cells were used as positive controls. GH 3 cells have been shown previously to express TRs (28) .
After a further 24 h, medium was aspirated, and the cells were harvested for extraction of nuclear proteins as described previously (10) . The protein content of the nuclear extracts was determined using the Bradford protein assay (Bio-Rad Laboratories, Inc., Hemel Hempstead, UK).
Prestained SDS protein standards (Bio-Rad Laboratories, Inc.) and 20 g protein extract were diluted 1:1 in loading buffer [4% SDS, 20% glycerol, 0.1% dithiothreitol, 125 mm Tris-HCl (pH 6.8), and 0.005% bromophenol blue dye], and loaded onto 12.5% polyacrylamide gel (Bio-Rad Laboratories, Inc.). The samples were electrophoresed at 120 mV for 40 min, electroblotted at 100 mV for 1 h onto nitrocellulose paper, and then blocked for an additional 1 h in PBS plus 0.1% Tween 20 (PBS-T; Sigma) containing 20% nonfat milk (Marvel, Premier Brands, Stafford, UK). Proteins were then incubated overnight with primary antibody diluted 1:400 in PBS-T and then with secondary antibody diluted 1:20,000 in PBS-T for 1 h. TR protein was detected using enhanced chemiluminescence (ECL Western Blotting Reagents, Amersham Pharmacia Biotech, Little Chalfont, UK) after exposure of the nitrocellulose to x-ray film (ECL Hyperfilm, Amersham Pharmacia Biotech) for 10 sec to 15 min.
Using Whole-Band Analysis software (BioImage Computer Systems, Crewe, UK), each negative was scanned, the image was digitized, and the OD of each band was measured. The coefficients of variations for repeated measurements were less than 20%. The linear quantitative detection of each receptor isoform was optimized to enable TR isoform expression to be compared among cell types.
Immunocytochemistry
Specific rabbit polyclonal anti-TR-␣1 and -␤1 antibodies were obtained from Affinity BioReagents, Inc. (Golden, CO). We have shown that these antibodies react specifically with the TR isoforms in osteoblastic cell lines (10) and have used them previously in immunocytochemistry studies (29) . The TR␤2 antibody was obtained from Prof. V. K. K. Chatterjee (University of Cambridge). This was also a rabbit polyclonal directed to the N-terminal domain of the human ␤2 fused to glutathione-S-transferase.
Cells were plated at a density of 3 ϫ 10 5 to 5 ϫ 10 5 on coverslips (BDH Laboratories, Poole, UK) and allowed to settle overnight, followed by incubation for 24 h in ␣MEM with 10% CS-FCS. Cells were then treated with either no stimulant (negative control) or T 3 (1 or 10 nm) for an additional 24 h before being fixed in 10% formalin for 10 min. Endogenous peroxidase activity was removed with 1.5% H 2 O 2 . Coverslips were then incubated in blocking buffer (0.1 m PBS-T and 1% goat serum) for 1 h, washed in 0.1% PBS, and left overnight in primary antibody diluted 1:400 in 0.1 m PBS-T. Controls were processed in the absence of primary antibody. After three 15-min washes in 0.1 m PBS-T, cells were incubated for 1 h in secondary antibody (horseradish peroxidase, Amersham Pharmacia Biotech) diluted 1:800 in 0.1 m PBS-T. Peroxidase activity was visualized with diaminobenzamine tetrahydrochloride plus 0.1% H 2 O 2 . After three 15-min washes in 0.1 m PBS, coverslips were dehydrated in graded alcohol and mounted with Depex (BDH Laboratories). To standardize staining, the protocol was adhered to strictly, and cells were stained in batches that included samples from all cell types. TR expression was compared semiquantitatively within each batch. The total cell count and the number of stained cells were assessed in at least three coverslips (three to five fields per coverslip at ϫ100 magnification) using an Olympus Corp. CK-2 microscope (New Hyde Park, NY).
For colocalization of ALP-positive and TR-positive cells, a duplicate set of cells in each experiment was stained for alkaline phosphatase immediately after fixation and before immunocytochemistry for TR as described above. At the end of each specified incubation period, nuclear extracts were prepared as described above. The radioactivity associated with nuclear extracts was analyzed using an NE 1600 ␥-counter (Nuclear Enterprises, Dorset, UK). The protein content of the nuclear extracts was determined using the Bradford protein assay. Each incubation was performed in duplicate, and experiments on each cell type were performed on two separate occasions.
Statistical analysis
Results are expressed as the mean Ϯ sem for each experimental group and were compared by one-way ANOVA. When the F statistic was significant (P Ͻ 0.05), the analysis was continued using Fischer's multiple comparisons test.
Results
Immunocytochemistry
The immunostaining characteristics of hOb, hBMS, MG63, and SaOs-2 cells were determined using specific antibodies to TR␣1, TR␤1, and TR␤2. Figure 1 (A-C) shows that all cell types demonstrated expression of TR␣1, TR␤1, and TR␤2. Staining was compared among the four cell types within each batch. Staining with all three isoform-specific antibodies was similar in MG63, SaOs-2, and hBMS cells, but was less in hOb. All TR antibodies gave rise to some cytoplasmic staining, as noted previously (8, 14) . Dual staining for ALP and TR (␤1) confirmed that the positive nuclear stain for thyroid receptors was within ALP-positive cells (Fig. 1D) . However, not all ALP-positive cells were positive for TR staining. There was no staining visible on control slides processed in the absence of primary antibody. 
Western analyses
Protein expression was determined by Western blotting using the same antibodies as those used for immunocytochemistry. TR␣1 (48 kDa), TR␤1 (55 kDa), and TR␤2 (52 kDa) proteins of appropriate sizes (31, 32) were detected in each cell type (Fig. 2) and comigrated with 5-10 g of either in vitro translated cDNA for TR␤1 and TR␤2 (Prof. V. K. K. Chatterjee, University of Cambridge) or nuclear protein extracts from the well characterized, TR-positive, pituitary GH 3 cells. Levels of TR proteins were quantified using scanning densitometry. TR␣1 expression was higher in MG63 (5.0 Ϯ 0.9-fold) and hBMS were also assessed by Western analysis. Twenty-four-hour treatments with T 3 (1 and 10 nm) did not alter levels of TR␣1, TR␤1, and TR␤2 in any cell type. Figure 3 
Nuclear binding
Transient expression assays
To determine whether the endogenous receptors expressed in the cells were functional, all cell types were transfected with a plasmid containing TREs linked to a luciferase reporter gene (Fig. 4) . Basal expression of the TRE-containing reporter gene was approximately 1.8-fold greater than the control TKLUC in the untreated cells. In MG63 and hBMS cells, T 3 treatment stimulated further expression of this construct, and luciferase activity increased 4.7 Ϯ 0.9-and 5.5 Ϯ 0.7-fold, respectively, compared with controls (P Ͻ 0.05), confirming the presence of endogenous receptors. A further, highly significant (P Ͻ 0.001), response to T 3 stimulation was demonstrated in MG63 (13.1 Ϯ 2.3-fold) and hBMS (11.2 Ϯ 2.0-fold) cotransfected with the T 3 receptor expression vector RSVerbA␤. This rise was absent in unstimulated cultures.
In SaOs-2 and hOb cells, T 3 treatment had no further effect on TRE-TKLUC expression (2.0 Ϯ 0.4-and 1.5 Ϯ 0.2-fold, respectively; P Ͼ 0.05). However, in cells transfected with RSVerbA␤, a significant response was seen, albeit lower than in MG63 and hBMS cells (SaOs-2, 5.2 Ϯ 0.6-fold; hOb, 4.6 Ϯ 0.4-fold; P Ͻ 0.01). The luciferase activity of the control TKLUC remained unaffected by the presence or absence of T 3 .
In none of the above studies were there any apparent difference observed in T 3 R expression or response to T 3 between hBMS or hOb cells from different donors.
Discussion
We have described for the first time the expression of TR isoforms in primary cultures of human osteoblasts and bone marrow stromal cells and shown that the TR␣1, TR␤1, and TR␤2 isoforms are present in primary cultures as well as osteoblast cell lines. Their relative expression varies with cell type, but receptor expression does not necessarily predict function. In particular, this work has highlighted the importance of human bone marrow in thyroid and bone physiology.
Immunocytochemistry demonstrated similar staining intensities for all three isoforms in MG63, SaOs-2, and hBMS cells, but weaker staining in hOb. However, it is important to remember that in analyses based on the use of specific antibodies, levels of the isoforms are not strictly comparable within any one cell because of the use of separate antibodies with unquantified affinities for TR antigen. Some diffuse cytoplasmic staining was observed, although the nuclear staining was more intense and localized. This has been observed previously in MG63 cells and also in other tissues (8, 14) . TRs are constitutively localized to the nucleus, and thus cytoplasmic immunostaining may be nonspecific, representing leakage of antigen from the nucleus or weak cross-reactivity of these antibodies with unknown proteins.
Western analyses demonstrated protein for TR␣1, TR␤1, and TR␤2 in all cell types studied. Overall, TR expression was low in hOb compared with MG63 and hBMS cells. Other studies have also demonstrated differential expression of TR. In rat cell lines, Williams et al. (10) demonstrated variation in TR protein with osteoblast phenotype. In the preosteoblast UMR106 and the mature ROS 17/2.8 cells, the expression of TR␤1 was 2-and 5-fold greater, respectively, than that of TR␣1. In fibroblast-like immature ROS 25/1, this relationship was reversed. An analogous situation was seen in the developing rat and chick brain, where TR␣1 and TR␣2 appear very early before thyroid hormone is available (35) , whereas TR␤1 expression correlates with the onset of endogenous T 3 production (36). The relatively low level of TR protein expression in hOb cells is consistent with cytokine secretion data. These data show that in contrast to MG63 and hBMS cells, hOb are poorly responsive to hormones such as T 3 (17) , PTH, or 1,25-(OH) 2 D 3 (37) . Moreover, IL-6, normally a powerful stimulator of bone resorption, has no effect in hOb (38) . These results argue against a major role for these cells in osteotropic hormone-induced bone resorption. In contrast, hBMS cells express TR and are T 3 responsive, and our data would suggest that they, rather than hOb, represent the site of T 3 action. A relative predominance of TR␣1 was also apparent in MG63 and hBMS, consistent with skeletal defects seen in TR␣ Ϫ/Ϫ knockout mice. These mice show growth arrest and delayed bone maturation with disrupted endochondral bone formation associated with biochemical hypothyroidism (39) . In contrast, TR␤ Ϫ/Ϫ mice have little disruption of skeletal development (40) , and double knockout of both TR␣ and TR␤ genes (TR␣ Ϫ/Ϫ TR␤ Ϫ/Ϫ ) fails to worsen the TR␣ Ϫ/Ϫ phenotype (41). Thus, TR␣ seems essential for bone development and function, whereas TR␤ appears not to be as critical. However, the skeletal abnormalities of TR␣ Ϫ/Ϫ knockout mice are reversible with T 3 replacement, demonstrating firstly that the growth disruption results from biochemical hypothyroidism and secondly that TR␤ can be functional and compensate for TR␣ if required (39) . In the light of this, the predominance of TR␣ in the highly responsive MG63 and hBMS cells may be particularly relevant. We also demonstrated for the first time evidence for TR␤2 protein expression in human osteoblasts. TR␤2 expression in rodent bone was recently investigated (12) , but no TR␤2 mRNA was demonstrated. Their negative and our positive results may be related to discrepancies in the mRNA/protein ratios of TRs in bone, which are well described (42, 43) , particularly for ␤2. For example, in rodent liver, kidney, and heart, despite only trace detectable mRNA, TR␤2 contribution to total nuclear binding is up to 20% (44) . ␤2 mRNA may be difficult to detect because it is either expressed at very low levels (and efficiently translated) or is unstable and has a high turnover, making the RNA hard to detect. The contribution of the ␤2 isoform to bone physiology remains a subject for future investigations.
We used transient transfections assays to determine whether cell-specific differences in TR expression correlated with T 3 responsiveness. In MG63 and hBMS cells, which expressed relatively high levels of all isoforms, there was a significant T 3 -dependent induction of LUC activity, indicating that the endogenous TRs were functional. In hOb there was no such rise seen in LUC activity. We would suppose that the level of TR expression in these cells is too low for endogenous receptor function to be detected by the transfection assays employed. Interestingly, in SaOs-2 cells, which expressed TR protein in equivalent amounts to MG63 and hBMS cells, TRE activation was also absent. The difference in responses between the different cell types may also reflect variable expression of RXR and RAR, both of which are heterodimerization partners for T 3 . Given that there are two TR genes (␣ and ␤) and three RXR and RAR (␣, ␤, and ␥) genes, coexpression of multiple receptor isoforms in a single cell may provide a basis for cell-specific responses.
When exogenous RSVerbA␤ was transfected into cells, T 3 -dependent expression of the LUC gene was significantly enhanced in MG63 and hBMS cells, respectively. This suggests that the abundance of endogenous TRs may modify T 3 -dependent regulation of genes. In these experiments cells contain multiple copies of the TRE. Several TREs may act cooperatively, as in the case of the estrogen response element (45) , and in the presence of excess TREs the availability of TRs may become important.
We found significant reversible binding of [ 125 I]T 3 in MG63 and hBMS cells. SaOs-2 and hOb had significantly lower specific binding compared with these T 3 -responsive cells. In contrast, Sato et al. (4) found no difference in the number of T 3 -binding sites between the T 3 -responsive ROS 17/2.8-2 and the T 3 -unresponsive ROS 17/2.8-3 cells, although their conclusions were based on rodent cell lines.
We have thus demonstrated cell-specific differences between hOb and hBMS cells with respect to receptor expression and function. From our work, which demonstrates lower cytokine secretion (17) and paucity of TR immunostaining, T 3 -binding sites, and functioning receptors, it would seem that hOb cells play a lesser role and hBMS cells a greater role than previously envisaged in T 3 regulation of bone remodeling. Physiological interpretation and extrapolation to in vivo models is premature, and there are no doubt many other cell-specific differences aside from differential TR isoform expression that may influence T 3 responsiveness. Regulatory mechanisms for thyroid hormones are coupled with retinoids. Possible differential expression of these nuclear receptors and/or differences in heterodimerization patterns in hOb vs. hBMS may correlate with the observed differences. Our study does establish a basis for T 3 action along the osteoblast lineage and emphasizes the importance of human bone marrow cells in future studies of T 3 action on bone.
